Research Topics
| W A OrensteinSummaryAffiliation: Emory University Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Immunizations in the United States: success, structure, and stressWalter A Orenstein
Emory University, Atlanta, Georgia, USA
Health Aff (Millwood) 24:599-610. 2005..Despite the successes, the system faces numerous challenges, including vaccine supply, cost, and safety; adult immunization; vaccine research and development; and biopreparedness...- The role of measles elimination in development of a national immunization programWalter A Orenstein
Department of Medicine and Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
Pediatr Infect Dis J 25:1093-101. 2006.... 
Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the providerWalter A Orenstein
Emory Vaccine Center, Atlanta, Georgia 30322, USA
Am J Med 121:S22-7. 2008....- Financing immunization of adults in the United StatesW A Orenstein
Emory University School of Medicine, Atlanta, Georgia, USA
Clin Pharmacol Ther 82:764-8. 2007..A recent review of clinical preventive services by Partnership for Prevention gave childhood immunization a perfect score of 10, based on clinically preventable burden and cost-effectiveness... 
Preventing influenza: vaccine systems and practices in the SoutheastJulie A Gazmararian
Emory Center on Health Outcomes and Quality, Dept of Health Policy and Management, Rollins School of Public Health, Emory Univ, 1518 Clifton Rd NE, Atlanta, GA 30322, USA
Public Health Rep 121:684-94. 2006....- Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessmentDavid S Stephens
Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA
Lancet 365:855-63. 2005..We assessed emergence of macrolide-resistant invasive S pneumoniae disease in Atlanta, GA, USA, before and after the licensing, in February 2000, of the heptavalent pneumococcal conjugate vaccine for young children... - Support for universal childhood vaccination against influenza among private pediatric clinics and public health departments in GeorgiaKaren Pazol
Research Programs, Division of Infectious Diseases, School of Medicine, Emory Vaccine Center, Emory University, Atlanta, Georgia 30322, USA
J Public Health Manag Pract 15:393-400. 2009..However, these facilities will need multiple forms of assistance... - Development of pediatric vaccine recommendations and policiesLarry K Pickering
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Semin Pediatr Infect Dis 13:148-54. 2002..The logistics of development and implementation of pediatric vaccine recommendations and policies are reviewed... - Psychosocial correlates of intention to receive an influenza vaccination among rural adolescentsJulia E Painter
Department of Behavioral Sciences and Health Education Emory University, Rollins School of Public Health, 1518 Clifton Road NE, Atlanta, GA 30322, USA
Health Educ Res 25:853-64. 2010..Future influenza vaccination efforts geared toward rural middle and high school students may benefit from addressing adolescent attitudes toward influenza vaccination... - Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseasesSaad B Omer
Hubert Department of Global Health, Rollins School of Public Health and the Emory Vaccine Center, Emory University, Atlanta, GA 30322, USA
N Engl J Med 360:1981-8. 2009.... - Influenza vaccination of health care workers: policies and practices of hospitals in a community settingJulie A Gazmararian
Emory Center on Health Outcomes and Quality, Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA
Am J Infect Control 35:441-7. 2007.... - Childhood immunization: laws that workAlan R Hinman
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
J Law Med Ethics 30:122-7. 2002..Policy makers must balance the need to provide individual choice with the need to protect children's health... - Vaccine policy changes and epidemiology of poliomyelitis in the United StatesLorraine Niño Alexander
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
JAMA 292:1696-701. 2004..To reduce the VAPP burden, national vaccination policy changed in 1997 from reliance on OPV to options for a sequential schedule of inactivated poliovirus vaccine (IPV) followed by OPV. In 2000, an exclusive IPV schedule was adopted... - Addressing the challenges to immunization practice with an economic algorithm for vaccine selectionB G Weniger
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Vaccine 16:1885-97. 1998.... - Pertussis in adults: epidemiology, signs, symptoms, and implications for vaccinationW A Orenstein
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 28:S147-50. 1999..Cost-benefit or cost-effectiveness analyses would be useful in developing vaccination policies for adults... - Vaccination policies and programs: the federal government's role in making the system workB Schwartz
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Prim Care 28:697-711, v. 2001..Using examples of newly recommended vaccines, this article describes the infrastructure that underlies a safe and effective program and highlights some of the opportunities and threats likely to impact the system in coming years... - Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of AmericaLarry K Pickering
National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Clin Infect Dis 49:817-40. 2009..This document includes 46 standards that, if followed, should lead to optimal disease prevention through vaccination in multiple population groups while maintaining high levels of safety... - Vaccine supply problems: a perspective of the Centers for Disease Control and PreventionLance E Rodewald
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
Clin Infect Dis 42:S104-10. 2006..The present article focuses on routine pediatric vaccines, including influenza virus vaccine... - Ischemic cardiac events during the Department of Health and Human Services Smallpox Vaccination Program, 2003David L Swerdlow
Smallpox Vaccine Adverse Events Monitoring and Response Activity, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Clin Infect Dis 46:S234-41. 2008..10; 95% PI, 3.5-15.7). After persons with >/=3 cardiac risk factors or known heart disease were deferred from vaccination, no ICEs were reported among an additional 6638 vaccinees... - Prioritization of pandemic influenza vaccine: rationale and strategy for decision makingBenjamin Schwartz
National Vaccine Program Office, US Department of Health and Human Services, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop E 05, Atlanta, GA 30333, USA
Curr Top Microbiol Immunol 333:495-507. 2009..This chapter reviews information on influenza vaccine production capacity, describes approaches used in the USA to set priorities for vaccination in the setting of limited supply, and presents a proposed strategy for prioritization... - Defining and assessing measles elimination goalsMark J Papania
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 189:S23-6. 2004..A panel of experts, convened in March 2000 to review the data, concluded that measles is no longer endemic in the United States... - Evaluation of the measles clinical case definitionSonja S Hutchins
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 189:S153-9. 2004..The low positive predictive value of the clinical case definition in settings of low incidence demonstrates that serological confirmation is essential to ensure an accurate diagnosis of measles when measles is rare... - Interdisciplinary epidemiologic and economic research needed to support a universal childhood influenza vaccination policyMargaret S Coleman
Health Services Research and Evaluation Branch, Immunization Services Division, National Immunization Program, Center for Disease Control and Prevention, Atlanta, GA 30333, USA
Epidemiol Rev 28:41-6. 2006.... - Measles elimination in the United StatesWalter A Orenstein
National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
J Infect Dis 189:S1-3. 2004 - Financing the delivery of vaccines to children and adolescents: challenges to the current systemMegan C Lindley
Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, 1600 Clifton Rd NE, Mail Stop E 52, Atlanta, GA 30333, USA
Pediatrics 124:S548-57. 2009..Challenges were considered from the perspectives of vaccine providers; state and local governments; insurers, employers, and other health care purchasers; vaccine manufacturers; and consumers... - Financing immunizations in the United StatesAlan R Hinman
Task Force for Child Survival and Development, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
Clin Infect Dis 38:1440-6. 2004..This paper summarizes the history of financing immunizations in the United States and discusses some current problems and proposed solutions... - Workshop on smallpox legal preparedness: what have we learned from smallpox legal preparedness?Gene W Matthews
Office of General Counsel, Centers for Disease Control and Prevention, Atlanta, GA, USA
J Law Med Ethics 31:39-40. 2003 - Commentary: the case for universal varicella immunizationJane F Seward
Centers for Disease Control and Prevention, Atlanta, GA, USA
Pediatr Infect Dis J 25:45-6. 2006 - A retrospective evaluation of hospitalizations for acute gastroenteritis at 2 sentinel hospitals in central Japan to estimate the health burden of rotavirusHajime Kamiya
Rollins School of Public Health, Emory University, Atlanta, Georgia, USA
J Infect Dis 200:S140-6. 2009..Two rotavirus vaccines have recently been licensed for use in >80 countries worldwide but not in Japan. To assess the value of introducing rotavirus vaccination in Japan, data on the burden of rotavirus disease are needed... - The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell responseRama S Akondy
Emory Vaccine Center and the Hope Clinic, Emory University School of Medicine, Atlanta, GA 30022, USA
J Immunol 183:7919-30. 2009.... - Guidelines for quality standards for immunizationPierce Gardner
Department of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794, USA
Clin Infect Dis 35:503-11. 2002 - Vaccine shortages: history, impact, and prospects for the futureAlan R Hinman
Task Force for Child Survival and Development, Decatur, Georgia 30030, USA
Annu Rev Public Health 27:235-59. 2006..Consequently, we will probably continue to see occasional shortages of vaccines in the United States in the next few years... - Adult immunization: what can we learn from the childhood immunization program?Alan R Hinman
Clin Infect Dis 44:1532-5. 2007 - Evolution of measles elimination strategies in the United StatesAlan R Hinman
Task Force for Child Survival and Development, Decatur, Georgia 30030, USA
J Infect Dis 189:S17-22. 2004..Ninth, once endemic transmission has been interrupted, internationally imported measles cases will continue and will cause small outbreaks. Tenth, collaborative efforts with other countries are essential to reduce imported measles cases... - Building an immunity fence against measlesWalter A Orenstein
J Infect Dis 196:1433-5. 2007 - Measles vaccines and the potential for worldwide eradication of measlesH Cody Meissner
Division of Pediatric Infectious Disease, Tufts New England Medical Center, University School of Medicine, 750 Washington St, Boston, MA 02111, USA
Pediatrics 114:1065-9. 2004..To address the possibility of worldwide control of measles, efforts to ensure high immunization rates among people in both developed and developing countries must be sustained... - Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectivenessEvan W Orenstein
Yale University, New Haven, CT, USA
Int J Epidemiol 36:623-31. 2007.... - Measles: the need for 2 opportunities for preventionWalter A Orenstein
Clin Infect Dis 42:320-1. 2006 - Disruptions in the supply of routinely recommended childhood vaccines in the United StatesJeanne M Santoli
Pediatr Infect Dis J 23:553-4. 2004 - Walter A. Orenstein, MD: a tribute from grateful pediatric and public health communitiesGeorges Peter
Division of Pediatric Infectious Diseases, Department of Pediatrics, Rhode Island Hospital and Brown Medical School, Providence, RI, USA
Pediatr Infect Dis J 23:803-5. 2004 - US Civilian Smallpox Preparedness and Response Program, 2003Raymond A Strikas
National Vaccine Program Office, US Department of Health and Human Services, Washington, DC, USA
Clin Infect Dis 46:S157-67. 2008..This smallpox preparedness program put into place a number of measures to advance the United States' readiness for a smallpox outbreak that have assisted in preparedness for other threats...
Research Grants
- Exploratory Center for Vaccinology Research (RMI)James Hughes; Fiscal Year: 2006....
- Exploratory Center for Vaccinology Research (RMI)Walter Orenstein; Fiscal Year: 2007..abstract_text> ..